期刊文献+

Heterochronic triple primary malignancies with Epstein-Barr virus infection and tumor protein 53 gene mutation:A case report and review of literature 被引量:1

下载PDF
导出
摘要 BACKGROUND The diagnosis and etiology of multiple primary malignant neoplasms(MPMNs)are difficult to establish.Here,we report a case of heterochronic triple primary malignancies with gastric cancer,nasopharyngeal squamous cell cancer,and then rectal cancer.CASE SUMMARY The patient was first diagnosed with gastric cancer at the age of 33 in 2014 and underwent distal gastrectomy and gastrojejunostomy and six cycles of adjuvant chemotherapy.Three years later,he was diagnosed with nasopharyngeal cancer and treated with radical chemoradiotherapy in 2017.Recently,a mass in the middle of the rectum was resected and reported as ulcerative,moderately to poorly differentiated adenocarcinoma.Research on the etiology of MPMNs showed that Epstein-Barr virus(EBV)infection may be the cause of gastric cancer and nasopharyngeal squamous cell cancer since these two primary lesions were positive for transcripts of EBV-encoded ribonucleic acid using an in situ hybridization EBV-encoded ribonucleic acid probe in formalin-fixed,paraffinembedded tissue.The cause of rectal cancer may be due to a somatic mutation of tumor protein 53 gene in exon 8(c.844C>T,p.Arg282Trp)through highthroughput sequencing for the rectal cancer.Appropriate standard therapy for each primary cancer was administered,and the patient has no evidence of cancer disease to date.CONCLUSION To our knowledge,this is the first report on heterochronic triple primary malignancies whose cause may be associated with EBV infection and tumor protein 53 genetic mutations.The etiological research may not only elucidate the cause of MPMN but also has implications in clinical management.
出处 《World Journal of Clinical Cases》 SCIE 2021年第5期1184-1195,共12页 世界临床病例杂志
  • 相关文献

参考文献1

二级参考文献20

  • 1Hongjie Zhang,Xiaoyi Kuai,Zeyu Ji,Zhengyang Li,Ruihua Shi.Over-Expression of Small Ubiquitin-Related Modifier-1 and Sumoylated p53 in Colon Cancer[J]. Cell Biochemistry and Biophysics . 2013 (3)
  • 2Tae-Hyoung Yoo,Jin-Hee Lee,Hyang-Sook Chun,Sung-Gil Chi.α-Lipoic acid prevents p53 degradation in colon cancer cells by blocking NF-κB induction of RPS6KA4[J]. Anti-Cancer Drugs . 2013 (6)
  • 3Isabel Cordero-Herrera,MaríaAngeles Martín,Laura Bravo,Luis Goya,Sonia Ramos.Epicatechin Gallate Induces Cell Death via p53 Activation and Stimulation of p38 and JNK in Human Colon Cancer SW480 Cells[J]. Nutrition and Cancer . 2013 (5)
  • 4Hana Janouskova,Anne-Marie Ray,Fanny Noulet,Isabelle Lelong-Rebel,Laurence Choulier,Florence Schaffner,Maxime Lehmann,Sophie Martin,Jan Teisinger,Monique Dontenwill.Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells[J]. Cancer Letters . 2013 (2)
  • 5Chiung‐Min Wang,Victoria C. Brennan,Ninoska M. Gutierrez,Xirui Wang,Lizhong Wang,Wei‐Hsiung Yang.SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene[J]. J. Cell. Biochem. . 2013 (3)
  • 6Manuel Rieber,Mary Strasberg-Rieber.Hypoxia, Mn-SOD and H 2 O 2 regulate p53 reactivation and PRIMA-1 toxicity irrespective of p53 status in human breast cancer cells[J]. Biochemical Pharmacology . 2012 (12)
  • 7Ignacio López,Ligia P. Oliveira,Paula Tucci,Fernando álvarez-Valín,Renata A. Coudry,Mónica Marín.Different mutation profiles associated to P53 accumulation in colorectal cancer[J]. Gene . 2012 (1)
  • 8Marc J.Rigatti,RajeevVerma,Glenn S.Belinsky,Daniel W.Rosenberg,CharlesGiardina.Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells[J]. Mol. Carcinog. . 2012 (5)
  • 9FrankEssmann,KlausSchulze‐Osthoff.Translational approaches targeting the p53 pathway for anti‐cancer therapy[J]. British Journal of Pharmacology . 2011 (2)
  • 10Mirela Nadler-Milbauer,Lior Apter,Ygal Haupt,Sue Haupt,Yechezkel Barenholz,Tamara Minko,Abraham Rubinstein.Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer[J]. Journal of Drug Targeting . 2011 (10)

共引文献31

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部